Tianjin TEDA Biomedical Engineering Company Limited (8189.HK)
- Previous Close
0.069 - Open
0.075 - Bid 0.062 x --
- Ask 0.077 x --
- Day's Range
0.075 - 0.075 - 52 Week Range
0.061 - 0.105 - Volume
55,000 - Avg. Volume
20,416 - Market Cap (intraday)
142.125M - Beta (5Y Monthly) 0.09
- PE Ratio (TTM)
-- - EPS (TTM)
-0.010 - Earnings Date May 8, 2024 - May 13, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Tianjin TEDA Biomedical Engineering Company Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of biological compound fertilizer products in the People's Republic of China. The company operates in three segments: Biological Compound Fertilizers Products; Elderly Care and Health Care Services; and Health Care Products (Wine) and Related Services. Its biological compound fertilizer products include active fertilizer, mixture with nitrogen, phosphorus, and potassium with various formula that are used for the facilitation of balanced growth of grains, fruits, and vegetables. The company is also involved in the provision of integrated elderly and health care; and elderly equipment leasing services, as well as consulting, advisory, and assessment services. In addition, it provides and licenses electroencephalography photography (EEG) diagnosis detection services; conducts EEG detection and diagnosis technology services. Further, the company engages in the research, development, manufacture, and application of biomedical science and technology projects; regional soil resources conditioning and remediation business; trading of wine and specializing in system platform development; and provision of soil environmental quality standards research services, as well as information transmission, software, and information technology service industry. Tianjin TEDA Biomedical Engineering Company Limited was incorporated in 2000 and is headquartered in Tianjin, the People's Republic of China.
www.bioteda.com264
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: 8189.HK
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 8189.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 8189.HK
Valuation Measures
Market Cap
142.12M
Enterprise Value
226.05M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.33
Price/Book (mrq)
2.63
Enterprise Value/Revenue
0.57
Enterprise Value/EBITDA
47.15
Financial Highlights
Profitability and Income Statement
Profit Margin
-5.07%
Return on Assets (ttm)
-3.77%
Return on Equity (ttm)
-15.05%
Revenue (ttm)
398M
Net Income Avi to Common (ttm)
-14.56M
Diluted EPS (ttm)
-0.010
Balance Sheet and Cash Flow
Total Cash (mrq)
5.93M
Total Debt/Equity (mrq)
129.39%
Levered Free Cash Flow (ttm)
-1.99M
Company Insights: 8189.HK
8189.HK does not have Company Insights